abstract |
3-SULPHONYLINDAZOL DERIVATIVES REPLACED AS 5-HYDROXYTHRIPTAMINE-6 BINDERS The present invention features a compound of formula 1 and its use for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor. |